4
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-058408
Chief Product & Tech Officer gave up 581 shares (to pay taxes)
- Chief Product & Tech Officer acquired 1,964 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Besch Doug Chief Product & Tech Officer | 2025-12-19 | Option exercise | +1,964 | 71,536 | D | ||
| Besch Doug Chief Product & Tech Officer | 2025-12-19 | Shares withheld for taxes | −581 | $13.51 | $7,849 | 70,955 | D |
| Derivatives | |||||||
| Besch Doug Chief Product & Tech Officer | 2025-12-19 | Option exercise · Restricted Stock Units | −1,964 | 1,964 | D | ||
Loading xslF345X05/wk-form4_1766416032.xml…